Featured

Breaking Down Moderna’s COVID-19 Patent Pledge: Why Did They Do It?

By Dan Shores on November 9, 2020

As Pfizer and BioNTech announced this week that results of their COVID-19 vaccine have exceeded expectations, the technology behind the…
Continue Reading Breaking Down Moderna’s COVID-19 Patent Pledge: Why Did They Do It?

In the fast-paced and dynamic environment of startup and emerging companies, standard operating procedures and compliance matters may often fall…
Continue Reading Is it Time to Re-evaluate (or Create) Your Document Retention Policy?

By Jennifer B. Maisel on November 5, 2020

At this point we have all heard how artificial intelligence (AI) will change the world, and many of us have…
Continue Reading USPTO Report Shows Tremendous Growth in Patent Filings on Artificial Intelligence

By Dan Shores on October 30, 2020

This week, Ryder System, Inc. (NYSE: R), announced a new corporate venture capital fund called RyderVentures.

By Eric D. Blatt on October 9, 2020

The Small Business Innovation Research (SBIR) program is U.S. government program that provides funding to small businesses conducting research and…
Continue Reading R&D Funding For Early Stage Companies – What is SBIR?

By Aydin H. Harston on October 7, 2020

On October 7, 2020, Scribe Therapeutics announced a collaboration with Biogen, to collaborate on CRISPR-based medicines for treating neurological…
Continue Reading Scribe Enters CRISPR-Based Collaboration with Biogen

By Dan Shores on October 6, 2020

Leaders of emerging companies must make many critical decisions at the outset of their company’s growth cycle, not the least…
Continue Reading Critical Steps for Building Winning Patent Portfolios